Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora

BackgroundSevere liver diseases, such as liver fibrosis, cirrhosis, and liver cancer, are mainly caused by hepatitis B virus (HBV). This study investigated the differences between gut microbiota in HBeAg-positive and negative groups of patients with chronic hepatitis B (CHB) and investigated the eff...

Full description

Bibliographic Details
Main Authors: Jianfei Long, Jingru Gong, Han Zhu, Xiaolin Liu, Ling Li, Bicui Chen, Hongyan Ren, Chao Liu, Huiping Lu, Jiming Zhang, Bin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Microbiology
Subjects:
hepatitis B virus
HBeAg
HBsAg
tenofovir alafenamide
gut microbiota
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1232180/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1232180/full

Similar Items